drugset
drugset / Trial / NCT03370536

ECGi Ibutilide: Effect of Ibutilide on AF Source Location and Organization

NCT03370536 ↗

Terminated 1 enrolled Vivek Reddy Medtronic · collab
NaSingle-groupOpen-labelTreatment

Summary

This is a prospective, multi-center, non-randomized, un-blinded, observational trial.

Timeline

Start
2017-11-01
Primary completion
2018-07-18
Completion
2018-07-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibutilide Small molecule 0.5 mg —

Indications

persistent atrial fibrillation